Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 19Gastrointestinal 18Gynecologic 11Genitourinary 10CNS 8Other hematologic neoplasm 6Other solid neoplasm 3Lymphoid 3Sarcoma 2Head & Neck 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Myeloid 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 1Melanoma 1Hematologic Neoplasms 1Glioma 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Genetic Testing × Dermatologic × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡